This work is licensed under the Creative Commons Attribution 4.0 International License.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; Authors/Task Force Members; Document Reviewers. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail. 2016, 18, 891–975.PonikowskiPVoorsAAAnkerSDBuenoHClelandJGCoatsAJFalkVGonzález-JuanateyJRHarjolaVPJankowskaEAJessupMLindeCNihoyannopoulosPParissisJTPieskeBRileyJPRosanoGMRuilopeLMRuschitzkaFRuttenFHvan der MeerPAuthors/Task Force Members;Document Reviewers. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESCEur. J. Heart Fail.20161889197510.1002/ejhf.59227207191Search in Google Scholar
Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002 Mar 21;346(12):877–883.MossAJZarebaWHallWJKleinHWilberDJCannomDSDaubertJPHigginsSLBrownMWAndrewsMLMulticenter Automatic Defibrillator Implantation Trial II InvestigatorsProphylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fractionN Engl J Med2002Mar213461287788310.1056/NEJMoa01347411907286Search in Google Scholar
Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225–237.BardyGHLeeKLMarkDBPooleJEPackerDLBoineauRDomanskiMTroutmanCAndersonJJohnsonGMcNultySEClapp-ChanningNDavidson-RayLDFrauloESFishbeinDPLuceriRMIpJHSudden Cardiac Death in Heart Failure Trial (SCD-HeFT) InvestigatorsAmiodarone or an implantable cardioverter-defibrillator for congestive heart failureN Engl J Med.2005352322523710.1056/NEJMoa04339915659722Search in Google Scholar
Díaz-Infante E, Mont L, Leal J, García-Bolao I, Fernández-Lozano I, Hernández-Madrid A, Pérez-Castellano N, Sitges M, Pavón-Jiménez R, Barba J, Cavero MA, Moya JL, Pérez-Isla L, Brugada J; SCARS Investigators. Predictors of lack of response to resynchronization therapy. Am J Cardiol 2005;95:1436–1440.Díaz-InfanteEMontLLealJGarcía-BolaoIFernández-LozanoIHernández-MadridAPérez-CastellanoNSitgesMPavón-JiménezRBarbaJCaveroMAMoyaJLPérez-IslaLBrugadaJSCARS InvestigatorsPredictors of lack of response to resynchronization therapyAm J Cardiol2005951436144010.1016/j.amjcard.2005.02.00915950566Search in Google Scholar
Lund LH, Jurga J, Edner M, Benson L, Dahlström U, Linde C, Alehagen U. Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction. Eur Heart J. 2013;34(7):529–539.LundLHJurgaJEdnerMBensonLDahlströmULindeCAlehagenUPrevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fractionEur Heart J.201334752953910.1093/eurheartj/ehs30523041499Search in Google Scholar
Butter C, Rastogi S, Minden HH, Meyhöfer J, Burkhoff D, Sabbah HN. Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure. J Am Coll Cardiol. 2008 May 6;51(18):1784–1789.ButterCRastogiSMindenHHMeyhöferJBurkhoffDSabbahHNCardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failureJ Am Coll Cardiol.2008May651181784178910.1016/j.jacc.2008.01.03618452785Search in Google Scholar
Gupta RC, Mishra S, Rastogi S, Wang M, Rousso B, Mika Y, Remppis A, Sabbah HN. Ca(2+)-binding proteins in dogs with heart failure: effects of cardiac contractility modulation electrical signals. Clin Transl Sci. 2009;2(3):211–215.GuptaRCMishraSRastogiSWangMRoussoBMikaYRemppisASabbahHNCa(2+)-binding proteins in dogs with heart failure: effects of cardiac contractility modulation electrical signalsClin Transl Sci.20092321121510.1111/j.1752-8062.2009.00097.x535073320443895Search in Google Scholar
Lyon AR, Samara MA, Feldman DS. Cardiac contractility modulation therapy in advanced systolic heart failure. Nat Rev Cardiol. 2013;10(10):584–598.LyonARSamaraMAFeldmanDSCardiac contractility modulation therapy in advanced systolic heart failureNat Rev Cardiol.2013101058459810.1038/nrcardio.2013.11423939481Search in Google Scholar
Tint D, Florea R, Micu S. New Generation Cardiac Contractility Modulation Device-Filling the Gap in Heart Failure Treatment. J Clin Med. 2019;8(5):588.TintDFloreaRMicuSNew Generation Cardiac Contractility Modulation Device-Filling the Gap in Heart Failure TreatmentJ Clin Med20198558810.3390/jcm8050588657216431035648Search in Google Scholar
Stix G, Borggrefe M, Wolpert C, Hindricks G, Kottkamp H, Böcker D, Wichter T, Mika Y, Ben-Haim S, Burkhoff D, Wolzt M, Schmidinger H. Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure. Eur Heart J. 2004;25(8):650–655.StixGBorggrefeMWolpertCHindricksGKottkampHBöckerDWichterTMikaYBen-HaimSBurkhoffDWolztMSchmidingerHChronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failureEur Heart J.200425865065510.1016/j.ehj.2004.02.02715084369Search in Google Scholar
Borggrefe MM, Lawo T, Butter C, Schmidinger H, Lunati M, Pieske B, Misier AR, Curnis A, Böcker D, Remppis A, Kautzner J, Stühlinger M, Leclerq C, Táborsky M, Frigerio M, Parides M, Burkhoff D, Hindricks G. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. Eur Heart J. 2008;29(8):1019–1028.BorggrefeMMLawoTButterCSchmidingerHLunatiMPieskeBMisierARCurnisABöckerDRemppisAKautznerJStühlingerMLeclerqCTáborskyMFrigerioMParidesMBurkhoffDHindricksGRandomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failureEur Heart J.20082981019102810.1093/eurheartj/ehn02018270213Search in Google Scholar
Kadish A, Nademanee K, Volosin K, Krueger S, Neelagaru S, Raval N, Obel O, Weiner S, Wish M, Carson P, Ellenbogen K, Bourge R, Parides M, Chiacchierini RP, Goldsmith R, Goldstein S, Mika Y, Burkhoff D, Abraham WT. A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. Am Heart J. 2011;161(2):329–337.e1–2.KadishANademaneeKVolosinKKruegerSNeelagaruSRavalNObelOWeinerSWishMCarsonPEllenbogenKBourgeRParidesMChiacchieriniRPGoldsmithRGoldsteinSMikaYBurkhoffDAbrahamWTA randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failureAm Heart J.20111612329337.e1–210.1016/j.ahj.2010.10.02521315216Search in Google Scholar
Abraham WT, Lindenfeld J, Reddy VY, Hasenfuss G, Kuck KH, Boscardin J, Gibbons R, Burkhoff D; FIX-HF-5C Investigators and Coordinators. A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with moderately reduced left ventricular ejection fraction and a narrow QRS duration: study rationale and design. J Card Fail. 2015;21(1):16–23.AbrahamWTLindenfeldJReddyVYHasenfussGKuckKHBoscardinJGibbonsRBurkhoffDFIX-HF-5C Investigators and CoordinatorsA randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with moderately reduced left ventricular ejection fraction and a narrow QRS duration: study rationale and designJ Card Fail.2015211162310.1016/j.cardfail.2014.09.011439099525285748Search in Google Scholar
Abraham WT, Kuck KH, Goldsmith RL, Lindenfeld J, Reddy VY, Carson PE, Mann DL, Saville B, Parise H, Chan R, Wiegn P, Hastings JL, Kaplan AJ, Edelmann F, Luthje L, Kahwash R, Tomassoni GF, Gutterman DD, Stagg A, Burkhoff D, Hasenfuß G. A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation. JACC Heart Fail 2018;6:874–883.AbrahamWTKuckKHGoldsmithRLLindenfeldJReddyVYCarsonPEMannDLSavilleBPariseHChanRWiegnPHastingsJLKaplanAJEdelmannFLuthjeLKahwashRTomassoniGFGuttermanDDStaggABurkhoffDHasenfußGA randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulationJACC Heart Fail2018687488310.1016/j.jchf.2018.04.01029754812Search in Google Scholar
Borggrefe M, Burkhoff D. Clinical effects of cardiac contractility modulation (CCM) as a treatment for chronic heart failure. Eur J Heart Fail 2012;14:703–712.BorggrefeMBurkhoffDClinical effects of cardiac contractility modulation (CCM) as a treatment for chronic heart failureEur J Heart Fail20121470371210.1093/eurjhf/hfs07822696514Search in Google Scholar
Liu, M.; Fang, F.; Luo, X.X.; Shlomo, B.-H.; Burkhoff, D.; Chan, J.Y.; Chan, C.-P.; Cheung, L.; Rousso, B.; Gutterman, D.; et al. Improvement of long-term survival by cardiac contractility modulation in heart failure patients: A case–control study. Int. J. Cardiol. 2016, 206, 122–126.LiuM.FangF.LuoX.X.ShlomoB.-H.BurkhoffD.ChanJ.Y.ChanC.-P.CheungL.RoussoB.GuttermanD.Improvement of long-term survival by cardiac contractility modulation in heart failure patients: A case–control studyInt. J. Cardiol.201620612212610.1016/j.ijcard.2016.01.07126788686Search in Google Scholar
Abraham WT, Nademanee K, Volosin K, Krueger S, Neelagaru S, Raval N, Obel O, Weiner S, Wish M, Carson P, Ellenbogen K, Bourge R, Parides M, Chiacchierini RP, Goldsmith R, Goldstein S, Mika Y, Burkhoff D, Kadish A; FIX-HF-5 Investigators and Coordinators. Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. J Card Fail. 2011;17(9):710–717.AbrahamWTNademaneeKVolosinKKruegerSNeelagaruSRavalNObelOWeinerSWishMCarsonPEllenbogenKBourgeRParidesMChiacchieriniRPGoldsmithRGoldsteinSMikaYBurkhoffDKadishAFIX-HF-5 Investigators and CoordinatorsSubgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failureJ Card Fail.201117971071710.1016/j.cardfail.2011.05.00621872139Search in Google Scholar
Anker SD, Borggrefe M, Neuser H, Ohlow MA, Röger S, Goette A, Remppis BA, Kuck KH, Najarian KB, Gutterman DD, Rousso B, Burkhoff D, Hasenfuss G. Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fraction. Eur J Heart Fail. 2019;21(9):1103–1113.AnkerSDBorggrefeMNeuserHOhlowMARögerSGoetteARemppisBAKuckKHNajarianKBGuttermanDDRoussoBBurkhoffDHasenfussGCardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fractionEur J Heart Fail.20192191103111310.1002/ejhf.137430652394Search in Google Scholar
Kuschyk J, Falk P, Demming T, Marx O, Morley D, Rao I, Burkhoff D. Long-term clinical experience with cardiac contractility modulation therapy delivered by the Optimizer Smart system. Eur J Heart Fail. 2021 May 17. doi: 10.1002/ejhf.2202.KuschykJFalkPDemmingTMarxOMorleyDRaoIBurkhoffDLong-term clinical experience with cardiac contractility modulation therapy delivered by the Optimizer Smart systemEur J Heart Fail2021May1710.1002/ejhf.2202836015934002440Open DOISearch in Google Scholar
Nägele H, Behrens S, Eisermann C. Cardiac contractility modulation in non-responders to cardiac resynchronization therapy. Europace 2008, 10, 1375–1380.NägeleHBehrensSEisermannCCardiac contractility modulation in non-responders to cardiac resynchronization therapyEuropace2008101375138010.1093/europace/eun25718776196Search in Google Scholar
Kuschyk J, Nägele H, Heinz-Kuck K, Butter C, Lawo T, Wietholt D, Roeger S, Gutterman D, Burkhoff D, Rousso B, Borggrefe M. Cardiac contractility modulation treatment in patients with symptomatic heart failure despite optimal medical therapy and cardiac resynchronization therapy (CRT). Int. J. Cardiol. 2019;277:173–177.KuschykJNägeleHHeinz-KuckKButterCLawoTWietholtDRoegerSGuttermanDBurkhoffDRoussoBBorggrefeMCardiac contractility modulation treatment in patients with symptomatic heart failure despite optimal medical therapy and cardiac resynchronization therapy (CRT)Int. J. Cardiol.201927717317710.1016/j.ijcard.2018.10.08630409733Search in Google Scholar
Röger S, Schneider R, Rudic B, Liebe V, Stach K, Schimpf R, Borggrefe M, Kuschyk J. Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation. Europace. 2014;16(8):1205–1209.RögerSSchneiderRRudicBLiebeVStachKSchimpfRBorggrefeMKuschykJCardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillationEuropace.20141681205120910.1093/europace/euu05024706089Search in Google Scholar